NEW MODEL: Jh mouse on B6 background Learn More

Taconic Biosciences News

Taconic Biosciences News is your source for current and relevant news on how animal models are being used to drive drug discovery. Use the links below to explore exciting announcements from Taconic via Press Releases, Taconic’s press activity in Media Coverage, and Taconic's commitment to being Models For Life™.

Cancer Researchers Get a Grip on Immune Cell Plasticity

Cancer Researchers Get a Grip on Immune Cell Plasticity

Certain of the body's immune cells, like macrophages, are particularly good at finding and destroying cancerous cells. But they also have the potential to switch gears and instead promote tumor cell growth. In an interview with Nature Methods, Taconic Biosciences' Dr. Paul Volden discusses the role of humanized immune system mouse models in exploring immune cell plasticity. Dr. Volden also reviews how Taconic's huNOG-EXL mouse is helping...  Read More

Taconic Biosciences Expands Scientific Advisory Board

Taconic Biosciences Expands Scientific Advisory Board

Dr. Monica Gostissa Joins Taconic Biosciences' Scientific Advisory Board Rensselaer, NY — March 15, 2021 - Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces Monica Gostissa, PhD, has joined its Scientific Advisory Board (SAB). Dr. Gostissa joins existing board members, Frank Sistare, PhD; Andrew Goodman, PhD; David Hill, PhD; and Robert Rosenthal, PhD. The SAB collaborates with Taconic management, providing scientific insight...  Read More

Animal Models Offer Improved Translatability

Animal Models Offer Improved Translatability

Positive results in preclinical research don't always equate to success in the clinic. To bridge the translation gap, animal model providers are continually enhancing and evolving their model portfolios. In an interview with Genetic Engineering & Biotechnology News, Taconic Biosciences' Dr. Terina Martinez discusses one of the company's newest offerings: a humanized immune system model that alleviates graft vs host disease and possesses mutations that make it...  Read More

As COVID-19 Research Evolves, So Too Will Animal Models

As COVID-19 Research Evolves, So Too Will Animal Models

Even as new vaccines roll out globally, the drug discovery work on COVID-19 is far from over. In an article in Drug Discovery News, Taconic Biosciences' Dr. Terina Martinez explores why infectious disease researchers will need to maintain or accelerate their efforts on both the vaccine and therapeutic fronts. She also discusses how animal models will evolve to support coronavirus research, citing the various types of models...  Read More

The Foundation for Biomedical Research Highlights Employees' "Real Pet Stories"

The Foundation for Biomedical Research Highlights Employees'

Animal research benefits other animals too! The Foundation for Biomedical Research (FBR), selected an employee of Taconic Biosciences for their "Real Pet Stories" blog. February is American Heart month. Gizomto's story, as told by Amy E. Sanderson, Taconic's IACUC Coordinator, shares how her cat was diagnosed and treated for advanced hypertrophic cardiomyopathy (HCM), a common heart disease in cats and one which also afflicts many humans. It...  Read More

Taconic Biosciences Expands Immuno-oncology Animal Model Portfolio

Taconic Biosciences Expands Immuno-oncology Animal Model Portfolio

Critical Jh Syngeneic Tumor Model Host Now Available on a B6 Background Rensselaer, NY — January 18, 2021 - Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces an expansion of its immuno-oncology portfolio. Immuno-oncology is a leading research priority because it uses the body's own immune system to effectively treat some types of cancer. Syngeneic tumor animal models play a critical role...  Read More

Beyond Vaccines

Beyond Vaccines

Rolling out safe, efficacious COVID-19 vaccines worldwide will be a formidable challenge that will take time, causing many more people to become infected in the meantime. In an interview with Drug Discovery News, Taconic Biosciences' Dr. Terina Martinez lent her insights on the need to develop effective COVID-19 therapeutics and the role of mouse models in advancing this important research: “"What we're talking about is finding that...  Read More

Quality Department Chooses to "Adopt-a-Family"

Quality Department Chooses to

The Holiday Season, while often a joyous time of year, can also be a very stressful time of year for many individuals and families. To add to this a global pandemic, the Holiday Season of 2020 left several people in various forms of need, whether that be emotionally, financially, or both. The Quality Department at Taconic Biosciences found a way to spread some holiday cheer, enriching people's...  Read More

Taconic Biosciences Expands Innovative ExpressMODEL® Portfolio

Taconic Biosciences Expands Innovative ExpressMODEL® Portfolio

New Random Integration Transgenic Animal Model Generation Solution Available Rensselaer, NY — December 3, 2020 - Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces the launch of the new ExpressMODEL®: Random Integration Transgenic (RITg) service, which reduces animal model generation costs and timeline. Many gene editing technologies are used to generate animal models for drug discovery, each with unique considerations but with...  Read More

Learning More About Animal Models for COVID-19 Research

Learning More About Animal Models for COVID-19 Research

Mouse models are playing an integral role in COVID-19 drug discovery, both for vaccines and targeted therapeutics. In an interview with LAS Pro, Taconic Biosciences' Dr. Megan MacBride shared her insights on the many types of models helping to advance COVID-19 research, including transgenic mice that express human ACE2, mice that transgenically express human HLA variants, and mice that express human ApoE alleles associated with severe COVID-19...  Read More

Close

Welcome! Tell us a little about yourself